A cancer diagnosis platform product utilizing GeneCker's ultra-precision CRISPR/Cas9 technology for standardization of liquid biopsy diagnosis. Integrates sample collection, DNA sequencing via NGS or Sanger sequencing methods, and provides results in result booklet or PDF format.
Manufactured by
Seoul, South Korea
GeneCker is a biotechnology company specializing in ultra-precision CRISPR technology and the MUTE-Seq® platform—an ultrasensitive liquid-biopsy NGS solution. From research and development to kit manufacturing, we provide an end-to-end service for advanced cancer genomics. Our flagship CRISPincette MultiCancer kit incorporates both our patented MUTE-Seq® and CRISPR Cas9 technologies to enrich variant-containing DNA fragments for accurate multi-cancer risk assessment. With operations in Korea, China, and other global markets, GeneCker delivers solutions for Multi-Cancer Early Detection (MCED) and Minimal Residual Disease (MRD) monitoring at ~20× higher analytical precision and one-tenth the per-sample cost compared to conventional UMI-based NGS.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
GENETRON HEALTH (BEIJING) CO., LTD
China · 6 relevant products
Intelligenome
United States · 2 relevant products
Eone-Diagnomics Genome Center
South Korea · 2 relevant products
Burning Rock Dx Co. Ltd.
China · 5 relevant products
Aliko Scientific SA
France · 3 relevant products
Xi'an Tianlong Science And Technology Co., Ltd
China · 1 relevant product
Rapid Viral Detection Systems
United States · 1 relevant product
Genomtec S.A.
Poland · 1 relevant product
BioChain (Beijing) Science & Technology. Inc.
China · 3 relevant products
Shenzhen HaploX Biotechnology Co., Ltd.
China · 2 relevant products
38 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →7 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 77 closest product alternatives
GENETRON HEALTH (BEIJING) CO., LTD · China
Comprehensive genomic sequencing platform for cancer diagnosis and characterization. Utilizes next-generation sequencing technology to identify genetic mutations and alterations in tumor samples. Supports treatment selection and clinical decision-making for oncology patients.
Intelligenome · United States
CRISPR-based diagnostic assay for oncology applications. Provides molecular detection and monitoring capabilities for cancer-related diagnostics.
Eone-Diagnomics Genome Center · South Korea
Liquid biopsy diagnostic platform for comprehensive genomic analysis and disease screening. Enables detection of genetic markers and abnormalities through blood-based testing.
Burning Rock Dx Co. Ltd. · China
OncoCompass® is a CE-marked liquid biopsy kit for comprehensive cancer mutation profiling using circulating tumor DNA analysis. Designed for non-invasive oncology assessment, it enables detection and characterization of cancer-associated mutations from blood samples to support treatment planning and monitoring.
GENETRON HEALTH (BEIJING) CO., LTD · China
Multi-biomarker screening solution for early-stage cancer identification. Analyzes blood samples to detect cancer-associated molecular signatures. Facilitates timely clinical intervention and improved patient outcomes.
Aliko Scientific SA · France
Advanced genetic testing platform for cancer diagnosis and personalized medicine applications. The system has been validated across thousands of real-world clinical scenarios for reliability and accuracy.
Burning Rock Dx Co. Ltd. · China
Circulating tumor DNA detection and analysis system for cancer diagnosis and monitoring. Enables early cancer detection through blood-based liquid biopsy technology with high sensitivity and specificity.
Xi'an Tianlong Science And Technology Co., Ltd · China
Molecular diagnostic kit for detecting genetic mutations and biomarkers associated with cancer. Supports precision oncology testing for treatment selection and monitoring.
Rapid Viral Detection Systems · United States
Point-of-care liquid biopsy platform for rapid cancer detection with 99% accuracy and high sensitivity. Delivers non-invasive screening results in minutes, enabling early diagnosis across multiple cancer types at a lower cost than conventional test kits.
Genomtec S.A. · Poland
An early-stage genetic diagnostic test platform designed for tumor-related genetic analysis and molecular profiling. The product is currently in development for point-of-care oncology applications.
BioChain (Beijing) Science & Technology. Inc. · China
Next-generation sequencing-based multiplex cancer screening panel for simultaneous detection of multiple cancer types. This advanced molecular diagnostic test enables comprehensive cancer risk stratification from single blood samples. The product is in development as part of the company's precision oncology pipeline.
Shenzhen HaploX Biotechnology Co., Ltd. · China
A core gene detection series focused on key cancer-related genes for clinical diagnostics. This test provides essential genomic profiling for oncology patients.
65 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products